Regulations.gov document
Guidance for Industry; Systemic Lupus Erythematosus — Developing Medical Products for…
Other · FDA-2010-D-0249 · posted Jun 21, 2010
Key facts
| Document ID | FDA-2010-D-0249-0004 |
|---|---|
| Title | Guidance for Industry; Systemic Lupus Erythematosus — Developing Medical Products for Treatment |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2010-D-0249 |
| Posted | Jun 21, 2010 |
| Comment period opens | Jun 21, 2010 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: